Comments*

 
  • Events 

    September 21 - 23, 2016

    13th Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms

    Featuring: Peder Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.

    Thursday, November 3, 2016 | 9:00 AM - 5:00 PM

    Microbial Influences in Cardio–Metabolic Diseases

    Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Louvain Drug Research Institute, Metabolism and Nutrition), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), and Dan Winer (University of Toronto)

    The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.

  • Past Events

    Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)

    Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.

    Wednesday, May 25, 2016 | 11:30 AM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Speakers: Philip A. Cole (Johns Hopkins University School of Medicine), Kenneth W. Duncan (Epizyme, Inc.)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2016, the annual year-end meeting features keynote speakers Dr Philip Cole and Dr Kenneth Duncan.

    May 18 - 20, 2016

    The Addicted Brain and New Treatment Frontiers: Sixth Annual Aspen Brain Forum

    Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)

    Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.

    Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM

    Arrested Development: The Teenage Brain and Substance Abuse

    Moderator: Claudia Wallis (Scientific American Mind)
    Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), Cheryl Healton (College of Global Public Health, New York University), and Honorable Gregory P. Canova, JD

    1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.

  • Publications 

    eBriefing

    Sohn Conference: Pediatric Cancer in a Post-genomic World

    Keynote Speakers: Richard Gilbertson (Cambridge Cancer Centre, University of Cambridge, UK) and Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    This eBriefing covers the latest research on pediatric cancers.

    eBriefing

    Epigenetics: Cancer and Beyond

    Organizers: Donald McCaffery (Resverlogix Corp.), Norman Wong (Resverlogix Corp.), Sarah Zapotichny (Resverlogix Corp.), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
    Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals issue presents a meeting report on mobile health technology in clinical trials and five original research articles discussing topics related to β-thalassemia major, Alzheimer's disease, hematopoiesis, hepatosteatosis, and downbeat nystagmus.

    Volume 1375

    Annals

    Special Issue: Nutrition and the Microbiome

    Edited by Karin Moelling (University of Zurich)


    Discussions of the link between nutrition and the gut microbiome